Quinolines by Cross-Dehydrogenative Coupling Reactions
[M]+. HRMS (EI): calcd. for C22H24N2O2 348.1832; found
348.1833.
of the coupling product 9a then decreased from 83 to 19%.
Based on the experimental results above, the reaction likely
proceeds by a radical pathway analogous to that described
in Scheme 3: iminium 5 deprotonates to give 6 as shown in
Scheme 5. Nucleophilic attack by the enamine derived from
cyclohexanone and pyrrolidine followed by hydrolysis leads
to the final product 9a and regenerates the pyrrolidine.
1
3c: H NMR (CDCl3, 400 MHz): δ = 8.21 (br. s, 1 H), 8.18 (s, 1
H), 8.04 (d, J = 8.8 Hz, 1 H), 7.52 (d, J = 8.6 Hz, 2 H), 7.48 (d, J
= 8.6 Hz, 2 H), 7.42 (dd, J = 8.8, 2.4 Hz, 1 H), 7.16 (d, J = 2.4 Hz,
1 H), 3.82 (s, 3 H), 3.11 (d, J = 4.8 Hz, 3 H) ppm. 13C NMR
(CDCl3, 101 MHz): δ = 165.44, 159.28, 147.31, 147.11, 143.32,
136.64, 134.87, 131.73, 130.80, 129.15, 128.86, 122.98, 119.53,
103.32, 55.70, 26.36 ppm. MS (EI): m/z = 326 [M]+. HRMS (EI):
calcd. for C18H15ClN2O2 326.0817; found 326.0821.
Conclusions
1
3e: H NMR (400 MHz, CDCl3): δ = 8.26 (s, 1 H), 8.24 (br. s, 1
We have developed a facile and economic method for the H), 8.06 (d, J = 9.2 Hz, 1 H), 7.78 (d, J = 8.0 Hz, 2 H), 7.71 (d, J
= 7.4 Hz, 2 H), 7.64 (d, J = 8.0 Hz, 2 H), 7.50 (t, J = 7.6 Hz, 2 H),
7.43 (m, 2 H), 7.32 (d, J = 2.4 Hz, 1 H), 3.84 (s, 3 H), 3.12 (d, J =
5.0 Hz, 3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 165.46,
159.01, 147.93, 147.24, 143.24, 141.37, 140.35, 137.00, 131.54,
129.87, 128.96, 128.91, 127.73, 127.41, 127.16, 122.73, 119.46,
103.56, 55.60, 26.25 ppm. MS (EI): m/z = 368 [M]+. HRMS (EI):
calcd. for C24H20N2O2 368.1525; found 368.1601.
functionalization of glycine derivatives. A series of substi-
tuted quinolines have been synthesized from commercially
inexpensive starting materials by using an inexpensive, read-
ily available catalyst. N-Arylglycine esters can also be func-
tionalized with ketones by FeCl3 in the presence of DDQ
under mild conditions. This reaction could be applicable to
other amino acids. The effectiveness of iron salts as cata-
lysts makes these processes especially interesting. Further
studies on the CDC reactions of secondary amines with
other C–H bonds by iron catalysis and the synthetic appli-
cations are in progress.
3f: 1H NMR (400 MHz, CDCl3): δ = 8.30 (s, 1 H), 8.25 (br. s, 1
H), 8.05 (d, J = 9.2 Hz, 1 H), 7.97 (s, 1 H), 7.89 (d, J = 8.4 Hz, 1
H), 7.82 (d, J = 9.6 Hz, 1 H), 7.63 (dd, J = 8.4, 1.7 Hz, 1 H), 7.42
(dd, J = 9.2, 2.8 Hz, 1 H), 7.31 (d, J = 2.7 Hz, 1 H), 7.26–7.21 (m,
2 H), 3.98 (s, 3 H), 3.77 (s, 3 H), 3.12 (d, J = 5.1 Hz, 3 H) ppm.
13C NMR (101 MHz, CDCl3): δ = 165.55, 158.96, 158.39, 148.39,
147.21, 143.26, 134.39, 133.27, 131.51, 129.82, 129.11, 128.87,
128.61, 127.58, 127.11, 122.72, 119.67, 119.60, 105.69, 103.60,
55.52, 55.43, 26.25 ppm. MS (EI): m/z = 372 [M]+. HRMS (EI):
calcd. for C23H20N2O3 372.1474; found 372.1553.
Experimental Section
General: Reagents were obtained commercially and used without
further purification unless indicated otherwise. Solvent was re-
moved under reduced pressure and the residue obtained was puri-
fied by chromatography on a silica gel column (300–400 mesh)
using a gradient solvent system (EtOAc/petroleum ether as eluent
unless specified otherwise). 1H and 13C NMR spectra were mea-
sured with a Bruker DPX-400 spectrometer. Chemical shifts [ppm]
were determined with tetramethylsilane (TMS) as internal refer-
ence. Mass spectra were determined with a Finnigan MAT 95 mass
spectrometer.
1
3g: H NMR (CDCl3, 400 MHz): δ = 8.31 (br. s, 1 H), 8.27 (s, 1
H), 8.15 (d, J = 9.2 Hz, 1 H), 7.99 (d, J = 8.8 Hz, 1 H), 7.77 (t, J
= 8.6 Hz, 1 H), 7.57 (t, J = 8.8 Hz, 1 H), 7.54 (m, 5 H), 3.12 (d, J
= 5.1 Hz, 3 H) ppm. 13C NMR (CDCl3, 101 MHz): δ = 165.40,
150.21, 149.53, 147.29, 137.89, 130.17, 130.03, 129.76, 128.77,
128.76, 128.00, 127.91, 126.14, 119.19, 26.43 ppm. MS (EI): m/z
= 262 [M]+. HRMS (EI): calcd. for C17H14N2O 262.1101; found
262.1098.
1
3h: H NMR (CDCl3, 400 MHz): δ = 8.28 (s, 1 H), 8.24 (br. s, 1
General Procedure for the Synthesis of 3a–l: Compounds 1a–d
(0.20 mmol), FeCl3 (0.02 mmol), phenylacetylene (0.24 mmol) and
(tBuO)2 (0.40 mmol) were successively added to DCE (1 mL) in a
Schlenk tube. The mixture was stirred for 12 h at 80 °C, filtered
through a small pad of silica gel and concentrated in vacuo. Flash
chromatography on silica gel using ethyl acetate/petroleum ether
(1:3) furnished the final product. The spectroscopic data for 3d are
consistent with the literature.[11e]
H), 8.07 (d, J = 9.6 Hz, 1 H), 7.94 (d, J = 2.0 Hz, 1 H), 7.69 (dd,
J = 9.6, 2.0 Hz, 1 H), 7.53 (m, 5 H), 3.12 (d, J = 4.8 Hz, 3 H) ppm.
13C NMR (CDCl3, 101 MHz): δ = 164.99, 149.71, 149.44, 145.63,
137.18, 134.12, 131.69, 131.04, 129.60, 129.06, 128.97, 128.53,
124.93, 119.97, 26.43 ppm. MS (EI): m/z = 296 [M]+. HRMS (EI):
calcd. for C17H13ClN2O 296.0711; found 296.0711.
3i: 1H NMR (CDCl3, 400 MHz): δ = 8.26 (s, 1 H), 8.22 (br. s, 1
H), 8.15 (d, J = 9.2 Hz, 1 H), 7.88 (d, J = 2.0 Hz, 1 H), 7.71 (dd,
J = 9.2, 2.0 Hz, 1 H), 7.54 (d, J = 8.8 Hz, 2 H), 7.45 (d, J = 8.8 Hz,
2 H), 3.12 (d, J = 4.8 Hz, 3 H) ppm. 13C NMR (CDCl3, 101 MHz):
δ = 164.85, 149.75, 148.12, 145.65, 135.57, 135.42, 134.43, 131.81,
131.23, 130.91, 129.31, 128.30, 124.60, 119.92, 26.45 ppm. MS (EI):
m/z = 330 [M]+. HRMS (EI): calcd. for C17H12Cl2N2O 330.0321;
found 330.0318.
1
3a: H NMR (CDCl3, 400 MHz): δ = 8.23 (br. s, 1 H), 8.21 (s, 1
H), 8.04 (d, J = 9.2 Hz, 1 H), 7.54 (m, 4 H), 7.52 (m, 1 H), 7.41
(dd, J = 9.2, 2.8 Hz, 1 H), 7.24 (d, J = 2.8 Hz, 1 H), 3.81 (s, 3 H),
3.11 (d, J = 5.2 Hz, 3 H) ppm. 13C NMR (CDCl3, 101 MHz): δ =
165.58, 159.08, 148.46, 147.35, 143.32, 138.22, 131.60, 129.51,
129.08, 128.85, 128.68, 122.82, 119.61, 103.68, 55.65, 26.36 ppm.
MS (EI): m/z = 292 [M]+. HRMS (EI): calcd. for C18H16N2O2
292.1206; found 292.1205.
3j: 1H NMR (CDCl3, 400 MHz): δ = 8.26 (s, 1 H), 8.24 (br. s, 1
3b: H NMR (CDCl3, 400 MHz): δ = 8.23 (br. s, 1 H), 8.21 (s, 1 H), 8.07 (d, J = 8.8 Hz, 1 H), 7.99 (d, J = 2.4 Hz, 1 H), 7.68 (dd,
1
H), 8.03 (d, J = 9.6 Hz, 1 H), 7.55 (d, J = 8.4 Hz, 2 H), 7.50 (d, J
= 8.4 Hz, 2 H), 7.41 (dd, J = 9.6, 2.4 Hz, 1 H), 7.33 (d, J = 2.4 Hz,
1 H), 3.84 (s, 3 H), 3.11 (d, J = 6.0 Hz, 3 H), 1.41 (s, 9 H) ppm.
13C NMR (CDCl3, 101 MHz): δ = 165.63, 158.99, 151.78, 148.46,
147.36, 143.35, 135.23, 131.58, 129.24, 129.11, 125.79, 122.57,
119.63, 104.01, 55.74, 34.91, 31.50, 26.34 ppm. MS (EI): m/z = 348
J = 8.8, 2.4 Hz, 1 H), 7.46 (d, J = 8.6 Hz, 2 H), 7.08 (d, J = 8.6 Hz,
2 H), 3.92 (s, 3 H), 3.12 (d, J = 5.2 Hz, 3 H) ppm. 13C NMR
(CDCl3, 101 MHz): δ = 165.13, 160.40, 149.69, 149.23, 145.75,
133.98, 131.70, 130.96, 130.85, 129.47, 128.71, 125.04, 119.83,
114.55, 55.58, 26.43 ppm. MS (EI): m/z = 326 [M]+. HRMS (EI):
calcd. for C18H15ClN2O2 326.0817; found 326.0817.
Eur. J. Org. Chem. 2012, 1583–1589
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1587